Xu Zaibin, Li Jiayu, Zhou Kaili, Wang Kongyan, Hu Huiyu, Hu Yingjie, Gao Yong, Luo Zhuohui, Huang Jiawen
Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
J Ethnopharmacol. 2024 Jul 15;329:118162. doi: 10.1016/j.jep.2024.118162. Epub 2024 Apr 7.
Exocarpium Citri Grandis (ECG), the epicarp of C. grandis 'Tomentosa' which is also known as Hua-Ju-Hong in China, has been widely used for thousands of years to treat inflammatory lung disorders such as asthma, and cough as well as dispelling phlegm. However, its underlying pharmacological mechanisms in acute lung injury (ALI) remain unclear.
To explore the therapeutic effect of ECG on ALI and reveal the potential mechanisms based on experimental techniques in vivo and in vitro.
Lipopolysaccharides (LPS) induced ALI in mice and induced RAW 264.7 cell inflammatory model were established to investigate the pharmacodynamics of ECG. ELISA kits, commercial kits, Western Blot, qPCR, Hematoxylin and Eosin (H&E) staining, immunohistochemistry, and immunofluorescence technologies were used to evaluate the pharmacological mechanisms of ECG in ameliorating ALI.
ECG significantly attenuated pulmonary edema in LPS-stimulated mice and decreased the levels of IL1β, IL6, and TNF-α in serum and BALF, reduced MDA and iron concentration as well as increased SOD and GSH levels in lung tissues, and also decreased the ROS level in BALF and Lung tissue. Further pharmacological mechanism studies showed that ECG significantly inhibited mRNA expression of inflammatory signaling factors and chemokines, and down-regulated the expression of TLR4, MyD88, NF-κB p65, NF-κB p-p65 (S536), COX2, iNOS, Txnip, NLRP3, ASC, Caspase-1, JAK1, p-JAK1 (Y1022), JAK2, STAT1, p-STAT1 (S727), STAT3, p-STAT3 (Y705), STAT4, p-STAT4 (Y693), and Keap1, and also up-regulated the expression of Trx-1, Nrf2, HO-1, NQO1, GPX4, PCBP1, and SLC40A1. In the LPS-induced RAW264.7 cell inflammatory model, ECG showed similar results to animal experiments.
Our results showed that ECG alleviated ALI by inhibiting TLR4/MyD88/NF-κB p65 and JAK/STAT signaling pathway-mediated inflammatory response, Txnip/NLRP3 signaling pathway-mediated inflammasome activation, and regulating Nrf2/GPX4 axis-mediated ferroptosis. Our findings provide an experimental basis for the application of ECG.
化橘红是化州柚“绒毛柚”的外果皮,在中国也被称为化橘红,数千年来一直被广泛用于治疗哮喘、咳嗽等肺部炎症性疾病以及祛痰。然而,其在急性肺损伤(ALI)中的潜在药理机制仍不清楚。
通过体内和体外实验技术,探讨化橘红对急性肺损伤的治疗作用,并揭示其潜在机制。
建立脂多糖(LPS)诱导的小鼠急性肺损伤模型和RAW 264.7细胞炎症模型,以研究化橘红的药效学。采用酶联免疫吸附测定试剂盒、商用试剂盒、蛋白质免疫印迹法、定量聚合酶链反应、苏木精-伊红(H&E)染色、免疫组织化学和免疫荧光技术,评估化橘红改善急性肺损伤的药理机制。
化橘红显著减轻LPS刺激小鼠的肺水肿,降低血清和支气管肺泡灌洗液(BALF)中白细胞介素1β(IL1β)、白细胞介素6(IL6)和肿瘤坏死因子-α(TNF-α)的水平,降低肺组织中丙二醛(MDA)和铁浓度,同时提高超氧化物歧化酶(SOD)和谷胱甘肽(GSH)水平,还降低BALF和肺组织中的活性氧(ROS)水平。进一步的药理机制研究表明,化橘红显著抑制炎症信号因子和趋化因子的mRNA表达,下调Toll样受体4(TLR4)、髓样分化因子88(MyD88)、核因子κB p65(NF-κB p65)、磷酸化核因子κB p65(S536)、环氧化酶2(COX2)、诱导型一氧化氮合酶(iNOS)、硫氧还蛋白相互作用蛋白(Txnip)、NOD样受体蛋白3(NLRP3)、凋亡相关斑点样蛋白(ASC)、半胱天冬酶-1(Caspase-1)、Janus激酶1(JAK1)、磷酸化JAK1(Y1022)、JAK2、信号转导子和转录激活子1(STAT1)、磷酸化STAT1(S727)、信号转导子和转录激活子3(STAT3)、磷酸化STAT3(Y705)、信号转导子和转录激活子4(STAT4)、磷酸化STAT4(Y693)以及 Kelch样环氧氯丙烷相关蛋白1(Keap1)的表达,同时上调硫氧还蛋白-1(Trx-1)、核因子E2相关因子2(Nrf2)、血红素加氧酶-1(HO-1)、醌氧化还原酶1(NQO1)、谷胱甘肽过氧化物酶4(GPX4)、聚胞嘧啶结合蛋白1(PCBP1)和溶质载体家族40成员1(SLC40A)的表达。在LPS诱导的RAW264.7细胞炎症模型中,化橘红的结果与动物实验相似。
我们的结果表明,化橘红通过抑制TLR4/MyD88/NF-κB p65和JAK/STAT信号通路介导的炎症反应、Txnip/NLRP3信号通路介导的炎性小体激活以及调节Nrf2/GPX4轴介导的铁死亡来减轻急性肺损伤。我们的研究结果为化橘红的应用提供了实验依据。